Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co (HKSE:01349) Operating Cash Flow per Share : HK$0.05 (TTM As of Mar. 2024)

View and export this data going back to 2002. Start your Free Trial

What is Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Operating Cash Flow per Share?

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co's operating cash flow per share for the three months ended in Mar. 2024 was HK$0.05. Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co's operating cash flow per share for the trailing twelve months (TTM) ended in Mar. 2024 was HK$0.05.

During the past 3 years, the average Operating Cash Flow per Share Growth Rate was -17.80% per year. During the past 5 years, the average Operating Cash Flow per Share Growth Rate was -16.60% per year. During the past 10 years, the average Operating Cash Flow per Share Growth Rate was 2.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the OCF Growth Rate using Operating Cash Flow per Share data.

The historical rank and industry rank for Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co's Operating Cash Flow per Share or its related term are showing as below:

HKSE:01349' s 3-Year OCF Growth Rate Range Over the Past 10 Years
Min: -22.9 Med: 10.35 Max: 34.9
Current: -17.8

During the past 13 years, Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co's highest 3-Year average Operating Cash Flow per Share Growth Rate was 34.90% per year. The lowest was -22.90% per year. And the median was 10.35% per year.

HKSE:01349's 3-Year OCF Growth Rate is ranked worse than
79.53% of 806 companies
in the Drug Manufacturers industry
Industry Median: 7.45 vs HKSE:01349: -17.80

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Operating Cash Flow per Share Historical Data

The historical data trend for Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co's Operating Cash Flow per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Operating Cash Flow per Share Chart

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Operating Cash Flow per Share

Get a 7-Day Free Trial

0.33

0.14

0.32

0.18

0.08

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Quarterly Data
	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Operating Cash Flow per Share	Get a 7-Day Free Trial															-0.21	-	-	-	0.05

Competitive Comparison of Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co's Operating Cash Flow per Share

For the Drug Manufacturers - Specialty & Generic subindustry, Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co's Price-to-Operating-Cash-Flow Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co's Price-to-Operating-Cash-Flow falls into.

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Operating Cash Flow per Share Calculation

Operating Cash Flow per Share is the amount of Cash Flow from Operations per outstanding share of the company's stock.

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co's Operating Cash Flow per Share for the fiscal year that ended in Dec. 2023 is calculated as

Operating Cash Flow per Share (A: Dec. 2023 )	=	Cash Flow from Operations (A: Dec. 2023 )	/	Shares Outstanding (Diluted Average) (A: Dec. 2023 )
	=	77.675	/	1034.170
	=	0.08

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co's Operating Cash Flow per Share for the quarter that ended in Dec. 2023 is calculated as

Operating Cash Flow per Share (Q: Mar. 2024 )	=	Cash Flow from Operations (Q: Mar. 2024 )	/	Shares Outstanding (Diluted Average) (Q: Mar. 2024 )
	=	47.73	/	1043.000
	=	0.05

Operating Cash Flow per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was HK$0.05

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Operating Cash Flow per Share Related Terms

Thank you for viewing the detailed overview of Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co's Operating Cash Flow per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co (HKSE:01349) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd (HKSE:01349) » Definitions » Operating Cash Flow per Share

Comparable Companies

Traded in Other Exchanges

688505:China

Address

No. 308, Cai Lun Road, Zhangjiang Hi-Tech Park, Pudong, Shanghai, CHN, 201210

Website

http://www.fd-zj.com

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd is engaged in the research, development, manufacturing, and sale of biopharmaceutical products. Its product portfolio includes ALA (Aminolevulinic acid Hydrochloride); FuMeiDa and Libord. Geographically, it derives revenue from Mainland China.

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co (HKSE:01349) Headlines

No Headlines